SANOFI Ltd.

5950.00INR -102.80 ( -1.70%) VOLUME : 22000
    Average Volume
  • 5-Day 14,000.00
  • 20-Day 18,500.00
  • 3-Months 19,192.31

MARKET CLOSED

Price Table

Date Open High GREEN: if High is higher than last 2 days high
RED: if high is lower than last 2 days high
Low GREEN:if Low is higher than last 2 days low
RED: if low is lower than last 2 days low
LTP Close GREEN:if Day's Closing is near the Day's High
RED: if low is lower than last 2 days low
Volume Delivery % 20 Day SMA GREEN: if Day's Closing is above 20-Day SMA
RED: if Day's Closing is below 20-Day SMA
50 Day SMA GREEN: if Day's Closing is above 50-Day SMA
RED: if Day's Closing is below 50-Day SMA
100 Day SMA GREEN: if Day's Closing is above 100-Day SMA
RED: if Day's Closing is below 100-Day SMA
200 Day SMA GREEN: if Day's Closing is above 200-Day SMA
RED: if Day's Closing is below 200-Day SMA
18-Oct-19 6300.00 6300.00 5920.15 5950.00 5996.25 22,155 58% 5,876.14 5,989.24 5,829.24 5,888.54
17-Oct-19 5995.00 6080.00 5980.00 6079.00 6052.80 4,607 72% 5,866.49 5,991.82 5,824.56 5,889.22
16-Oct-19 5910.40 5989.00 5877.65 5986.00 5980.55 11,322 91% 5,853.53 5,993.38 5,818.91 5,889.28
15-Oct-19 5879.00 5927.15 5850.00 5910.80 5893.10 15,096 87% 5,848.74 5,994.29 5,813.91 5,890.03
14-Oct-19 5949.40 5949.40 5838.55 5888.80 5879.55 16,798 87% 5,850.55 5,999.01 5,808.78 5,892.03
11-Oct-19 5710.00 5885.00 5681.05 5870.10 5878.85 98,749 92% 5,852.87 6,005.07 5,804.08 5,893.81
10-Oct-19 5819.30 5819.30 5695.00 5695.00 5702.95 16,937 91% 5,858.29 6,011.51 5,799.62 5,895.72

Performance

Key Data

Day High Low Range

Time Lowest Highest
10 AM 6056.05 6300.00
11 AM 6056.05 6300.00
12 PM 6056.05 6300.00
1 PM 6056.05 6300.00
2 PM 6056.05 6300.00

Company Profile - SANOFI Ltd.

SANOFI

In May 1956, Sanofi India or earlier known as Aventis Pharma (or APL) was being incorporated as Hoechst Fedco Pharma. Later the company name was changed to Hoechst Pharmaceuticals, Hoechst Marion Roussel, and Hoechst India. Also, the Sanofi-aventis is one of the world's leading pharmaceutical companies, and it is also the 100% subsidiary Hoechst GmbH that together holds up to 50.12% of its paid-up share capital. In India, the company operates via five entities such as Sanofi India Limited (earlier known as Aventis Pharma Limited), Sanofi Pasteur India Private Limited, Sanofi-Synthelabo (in India) Limited, Shantha Biotechnics Limited, and Genzyme India Private Limited. It also develops medicines in therapeutic areas such as thrombotic diseases, cardiovascular disease, metabolic disorders, and disorders of the central nervous system, oncology, internal medicine, and vaccines. Its product portfolio mainly consists of leading brands such as Cardac ... e, Clexane, Daonil, Taxotere, Lantus, Soframycin, Arava, Combiflam, Lasix, and many more. Also, the manufacturing facilities are being located at Ankleshwar (in Gujarat) and Goa. The Company’s Ankleshwar unit has also received the certification of ISO 14001 for the Environment Management System. It also exports to countries such as Russia, the UK, Sri Lanka, and Egypt are among others.

The Business areas of the Company:

A world-class R&D pipeline is backing the Company, and Sanofi India has several leading positions in the several major therapeutic areas such as:
  • Central Nervous System
  • Oncology
  • Arthritis and Osteoporosis
  • Primary Health Care
  • Vaccines
  • Consumer Healthcare
  • Cardiovascular Diseases
  • Thrombosis
  • Diabetes
  • Internal Medicine